Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
Standard
Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study. / Schönlein, Martin; Wrage, Victoria; Ghandili, Susanne; Mellinghoff, Sibylle C; Brehm, Thomas Theo; Leypoldt, Lisa B; Utz, Nils; Schrader, Roland M; Alsdorf, Winfried; Börschel, Niklas; Bußmann, Lara; Schönrock, Martin; Perlick, Dorothea; Schön, Gerhard; Verpoort, Karl; Lütgehetmann, Marc; Schulze Zur Wiesch, Julian; Weisel, Katja C; Bokemeyer, Carsten; Schafhausen, Philippe; Sinn, Marianne.
in: CANCER CELL, Jahrgang 40, Nr. 6, 13.06.2022, S. 581-583.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study
AU - Schönlein, Martin
AU - Wrage, Victoria
AU - Ghandili, Susanne
AU - Mellinghoff, Sibylle C
AU - Brehm, Thomas Theo
AU - Leypoldt, Lisa B
AU - Utz, Nils
AU - Schrader, Roland M
AU - Alsdorf, Winfried
AU - Börschel, Niklas
AU - Bußmann, Lara
AU - Schönrock, Martin
AU - Perlick, Dorothea
AU - Schön, Gerhard
AU - Verpoort, Karl
AU - Lütgehetmann, Marc
AU - Schulze Zur Wiesch, Julian
AU - Weisel, Katja C
AU - Bokemeyer, Carsten
AU - Schafhausen, Philippe
AU - Sinn, Marianne
PY - 2022/6/13
Y1 - 2022/6/13
U2 - 10.1016/j.ccell.2022.04.016
DO - 10.1016/j.ccell.2022.04.016
M3 - Other (editorial matter etc.)
C2 - 35512712
VL - 40
SP - 581
EP - 583
JO - CANCER CELL
JF - CANCER CELL
SN - 1535-6108
IS - 6
ER -